26 Aug 2024 · 1 min read
For those closely watching the evolution of the Digital Therapeutics (DTx) market, here's a note...
Following Pear's bankruptcy, their FDA-cleared DTx apps reSET and reSET-O have been relaunched by PursueCare — and I think it's a timely reminder that we may have been overly optimistic about digital therapeutics succeeding independently, and that go-to-market strategy deserves an open mind.